FGF21 and Mitochondrial myopathy: Notably, FGF21 is considered an established biomarker of human mitochondrial myopathy (Suomalainen, 2013), and as expected, plasma FGF21 levels were also increased in MERRF patients (8‐fold, Fig 4K).